Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

507 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Editorial: rethinking predictors of response to the low FODMAP diet - should we retire fructose and lactose breath-hydrogen testing and concentrate on visceral hypersensitivity? Authors' reply.
Wilder-Smith CH, Olesen SS, Materna A, Drewes AM. Wilder-Smith CH, et al. Among authors: drewes am. Aliment Pharmacol Ther. 2017 May;45(9):1282. doi: 10.1111/apt.14041. Aliment Pharmacol Ther. 2017. PMID: 28370046 No abstract available.
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply.
Hvid-Jensen F, Drewes AM, Funch-Jensen P. Hvid-Jensen F, et al. Among authors: drewes am. Aliment Pharmacol Ther. 2014 Oct;40(7):860-1. doi: 10.1111/apt.12931. Aliment Pharmacol Ther. 2014. PMID: 25185739 No abstract available.
Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients.
Hvid-Jensen F, Pedersen L, Funch-Jensen P, Drewes AM. Hvid-Jensen F, et al. Among authors: drewes am. Aliment Pharmacol Ther. 2014 May;39(9):984-91. doi: 10.1111/apt.12693. Epub 2014 Mar 11. Aliment Pharmacol Ther. 2014. PMID: 24617286
Letter: proton pump inhibitors, GERD and oesophageal adenocarcinoma - authors' reply.
Hvid-Jensen F, Funch-Jensen P, Drewes AM. Hvid-Jensen F, et al. Among authors: drewes am. Aliment Pharmacol Ther. 2014 Aug;40(3):320. doi: 10.1111/apt.12847. Aliment Pharmacol Ther. 2014. PMID: 25040747 No abstract available.
Established and emerging methods for assessment of small and large intestinal motility.
Grønlund D, Poulsen JL, Sandberg TH, Olesen AE, Madzak A, Krogh K, Frøkjaer JB, Drewes AM. Grønlund D, et al. Among authors: drewes am. Neurogastroenterol Motil. 2017 Jul;29(7). doi: 10.1111/nmo.13008. Epub 2017 Jan 13. Neurogastroenterol Motil. 2017. PMID: 28086261 Review.
Regional gastrointestinal contractility parameters using the wireless motility capsule: inter-observer reproducibility and influence of age, gender and study country.
Farmer AD, Wegeberg AL, Brock B, Hobson AR, Mohammed SD, Scott SM, Bruckner-Holt CE, Semler JR, Hasler WL, Hellström PM, Drewes AM, Brock C. Farmer AD, et al. Among authors: drewes am. Aliment Pharmacol Ther. 2018 Feb;47(3):391-400. doi: 10.1111/apt.14438. Epub 2017 Dec 6. Aliment Pharmacol Ther. 2018. PMID: 29210098 Clinical Trial.
Randomised clinical trial: pregabalin attenuates experimental visceral pain through sub-cortical mechanisms in patients with painful chronic pancreatitis.
Olesen SS, Graversen C, Olesen AE, Frøkjaer JB, Wilder-Smith O, van Goor H, Valeriani M, Drewes AM. Olesen SS, et al. Among authors: drewes am. Aliment Pharmacol Ther. 2011 Oct;34(8):878-87. doi: 10.1111/j.1365-2036.2011.04802.x. Epub 2011 Aug 16. Aliment Pharmacol Ther. 2011. PMID: 21848870 Clinical Trial.
Risk of peptic ulcer, oesophagitis, pancreatitis or gallstone in patients with unexplained chest/epigastric pain and normal upper endoscopy: a 10-year Danish cohort study.
Munk EM, Drewes AM, Gorst-Rasmussen A, Gregersen H, Funch-Jensen P, Nørgård B. Munk EM, et al. Among authors: drewes am. Aliment Pharmacol Ther. 2007 May 15;25(10):1203-10. doi: 10.1111/j.1365-2036.2007.03315.x. Aliment Pharmacol Ther. 2007. PMID: 17451566
Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy.
Brock C, Hansen CS, Karmisholt J, Møller HJ, Juhl A, Farmer AD, Drewes AM, Riahi S, Lervang HH, Jakobsen PE, Brock B. Brock C, et al. Among authors: drewes am. Br J Clin Pharmacol. 2019 Nov;85(11):2512-2523. doi: 10.1111/bcp.14063. Epub 2019 Aug 30. Br J Clin Pharmacol. 2019. PMID: 31338868 Free PMC article. Clinical Trial.
Predictors of response to a low-FODMAP diet in patients with functional gastrointestinal disorders and lactose or fructose intolerance.
Wilder-Smith CH, Olesen SS, Materna A, Drewes AM. Wilder-Smith CH, et al. Among authors: drewes am. Aliment Pharmacol Ther. 2017 Apr;45(8):1094-1106. doi: 10.1111/apt.13978. Epub 2017 Feb 24. Aliment Pharmacol Ther. 2017. PMID: 28233394
507 results
Jump to page
Feedback